Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Weidmann

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
International Journal of Clinical Pharmacy|July 21, 2025
Behavioural theories, models and frameworks to underpin clinical pharmacy and pharmacy practice research: guidance from the European Society of Clinical PharmacyAnita E Weidmann, Cathal Cadogan, Daniela Fialová, et al.
Annals of Hematology|October 24, 2000
Induction of apoptosis using 2',2' difluorodeoxycytidine (gemcitabine) in combination with antimetabolites or anthracyclines on malignant lymphatic and myeloid cells. Antagonism or synergism depends on incubation schedule and origin of neoplastic cellsK U Chow, J Ries, E Weidmann, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|June 26, 2001
Deregulated expression of prostate apoptosis response gene-4 in less differentiated lymphocytes and inverse expressional patterns of par-4 and bcl-2 in acute lymphocytic leukemiaS Boehrer, K U Chow, E Puccetti, et al.
Cancer Research|November 1, 1992
Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situE Weidmann, M Sacchi, S Plaisance, et al.
Leukemia & Lymphoma|April 28, 2000
Induction of apoptosis by 2-chloro-2'deoxyadenosine (2-CdA) alone and in combination with other cytotoxic drugs: synergistic effects on normal and neoplastic lymphocytes by addition of doxorubicin and mitoxantroneK U Chow, M J Rummel, E Weidmann, et al.
AIDS (London, England)|January 12, 2001
Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failureV Miller, C Sabin, K Hertogs, et al.
International Journal of Clinical Pharmacy|November 22, 2023
Scope, content and quality of clinical pharmacy practice guidelines: a systematic reviewVibhu Paudyal, Betul Okuyan, Martin Charles Henman, et al.
International Journal of Clinical Pharmacy|December 5, 2025
Correction: Research priorities of the European Society of Clinical Pharmacy (ESCP): a questionnaire-based studyBetul Okuyan, Martin C Henman, Vibhu Paudyal, et al.
International Journal of Clinical Pharmacy|June 20, 2025
Research priorities of the European Society of Clinical Pharmacy (ESCP): a questionnaire-based studyBetul Okuyan, Martin C Henman, Vibhu Paudyal, et al.
Onkologie|July 7, 2001
Treatment of aggressive, or progressing indolent peripheral T- and NK-cell neoplasias by combination of fludarabine, cyclophosphamide and doxorubicineE Weidmann, S Boehrer, K U Chow, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
International Journal of Clinical Pharmacy|July 21, 2025
Behavioural theories, models and frameworks to underpin clinical pharmacy and pharmacy practice research: guidance from the European Society of Clinical PharmacyAnita E Weidmann, Cathal Cadogan, Daniela Fialová, et al.
Annals of Hematology|October 24, 2000
Induction of apoptosis using 2',2' difluorodeoxycytidine (gemcitabine) in combination with antimetabolites or anthracyclines on malignant lymphatic and myeloid cells. Antagonism or synergism depends on incubation schedule and origin of neoplastic cellsK U Chow, J Ries, E Weidmann, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|June 26, 2001
Deregulated expression of prostate apoptosis response gene-4 in less differentiated lymphocytes and inverse expressional patterns of par-4 and bcl-2 in acute lymphocytic leukemiaS Boehrer, K U Chow, E Puccetti, et al.
Cancer Research|November 1, 1992
Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situE Weidmann, M Sacchi, S Plaisance, et al.
Leukemia & Lymphoma|April 28, 2000
Induction of apoptosis by 2-chloro-2'deoxyadenosine (2-CdA) alone and in combination with other cytotoxic drugs: synergistic effects on normal and neoplastic lymphocytes by addition of doxorubicin and mitoxantroneK U Chow, M J Rummel, E Weidmann, et al.
AIDS (London, England)|January 12, 2001
Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failureV Miller, C Sabin, K Hertogs, et al.
International Journal of Clinical Pharmacy|November 22, 2023
Scope, content and quality of clinical pharmacy practice guidelines: a systematic reviewVibhu Paudyal, Betul Okuyan, Martin Charles Henman, et al.
International Journal of Clinical Pharmacy|December 5, 2025
Correction: Research priorities of the European Society of Clinical Pharmacy (ESCP): a questionnaire-based studyBetul Okuyan, Martin C Henman, Vibhu Paudyal, et al.
International Journal of Clinical Pharmacy|June 20, 2025
Research priorities of the European Society of Clinical Pharmacy (ESCP): a questionnaire-based studyBetul Okuyan, Martin C Henman, Vibhu Paudyal, et al.
Onkologie|July 7, 2001
Treatment of aggressive, or progressing indolent peripheral T- and NK-cell neoplasias by combination of fludarabine, cyclophosphamide and doxorubicineE Weidmann, S Boehrer, K U Chow, et al.
Pageof 12